Public Company News
LexisNexis Risk Solutions Earns Three Technology Industry Awards for Its Fraud Prevention Solutions
LexisNexis® ThreatMetrix and LexisNexis Behavioral Biometrics Recognized for Capabilities that Help Businesses Fight Complex Fraud Through Digital Identity Intelligence and Authentication HONG KONG, Nov. 1, 2022 /PRNewswire/ -- LexisNexis® Risk Solutions announced that it won three technology aw...
2022-11-01 09:00
3619
CCV's Portfolio Perfect Corp. and Provident Acquisition Corp. Complete Business Combination
* Perfect's Shares and Warrants to Trade on the NYSE under Ticker Symbols " PERF" and "PERF WS" respectively BEIJING, Oct. 31, 2022 /PRNewswire/ -- CCV's early-stage portfolio company Perfect Corp. ("Perfect"), a global leader in providing augmented reality ("AR") and artificial intelligence ("A...
2022-11-01 09:00
3863
CARsgen Appoints Dr. Sylvie Peltier as Senior Vice President of Global Regulatory Affairs
SHANGHAI, Oct. 31, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thatDr. Sylvie Peltier ("Dr. Peltier") has been appointed as Senior V...
2022-10-31 21:30
3682
"Bleach: Brave Souls" Reaches Over 70 Million Downloads Worldwide
TOKYO, Oct. 31, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile
games, announced that its hit 3D action gameBleach: Brave Souls, currently
available on smartphones, PC, and PlayStation 4, has reached a total of 70
million downloads worldwide.
2022-10-31 21:30
3485
Announcement of the Effect of Ginseng and Red Ginseng for Memory Improvement and Suppression of Bone and Muscle Loss
* Effect of improving blood pressure in patients with high blood pressure and diabetes * Announced at the 13th International Symposium on Ginseng 2022 SEOUL, South Korea, Oct. 31, 2022 /PRNewswire/ -- Experts who have conducted scientific studies on the effect of ginseng gathered inSeoul from...
2022-10-31 21:08
4284
Gracell Biotechnologies to Report Third Quarter 2022 Financials on Monday, November 14, 2022
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Oct. 31, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today ...
2022-10-31 21:00
3131
iClick Interactive Announces ADS Ratio Change
HONG KONG, Oct. 31, 2022 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or "the Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform inChina that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced that it will change the...
2022-10-31 21:00
4928
Onion Global's LUCA Brand Matrix Launches Skincare Brand Dr.cekino
GUANGZHOU, China, Oct. 31, 2022 /PRNewswire/ -- Onion Global Limited ("Onion Global", the "Group" or the "Company") (NYSE: OG), a next-generation lifestyle brand platform that connects the world's fresh, fashionable, and future technology-based brands to young people inChina and across Asia, anno...
2022-10-31 20:30
4384
Tantech Holdings Receives NASDAQ Minimum Bid Price Requirement Extension And Announces Reverse Stock Split
LISHUI, China, Oct. 31, 2022 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), announced today that onOctober 28, 2022, it received notification from The Nasdaq Stock Market LLC ("NASDAQ") confirming the Company has been granted an additional 180 calendar day perio...
2022-10-31 20:30
3727
Ever-Glory Seeks Shareholders' Vote For Going-Dark and Announces $3.5 Million Stock Repurchase Program
NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Ever-Glory International Group, Inc. (the "Company" or "Ever-Glory") (NASDAQ: EVK), a retailer of branded fashion apparel and a leading global apparel supply chain solution provider, today filed a preliminary proxy statement to solicit votes for, among othe...
2022-10-31 20:30
4845
Antengene Receives U.S. FDA Clearance of IND Application for Phase I Trial of Small Molecule ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors
* ATG-017 is a small molecule ERK1/2 inhibitor and Antengene has obtained exclusive global rights to develop, commercialize and manufacture ATG-017. * IND clearance enables Antengene to initiate the combination portion of the Phase I "ERASER" clinical trial inthe United States (U.S.) to evalua...
2022-10-31 20:22
3765
Senhwa Announces First Patient Successfully Dosed in Phase I Study of Pindnarulex in Combination with Pfizer's Talazoparib for the Treatment of Prostate Cancer
TAIPEI and SAN DIEGO, Oct. 31, 2022 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced today that their first patient has been successfully dosed, in a phase I c...
2022-10-31 19:00
3422
IFS positioned highest on Ability to Execute and furthest on Completeness of Vision axes in the 2022 Gartner(R) Magic Quadrant(TM) for Field Service Management
IFS is a Gartner Magic Quadrant Leader for the 7th consecutive time LONDON, Oct. 31, 2022 /PRNewswire/ -- IFS, the global cloud enterprise applications company, is proud to be named a Leader for the seventh consecutive time in the Gartner Magic Quadrant for Field Service Management. In the 2022 ...
2022-10-31 17:32
3170
Aleees to support ICL on its in cathode active material manufacturing facility in St. Louis funded by the Bipartisan Infrastructure Law for the battery supply chain
TAIPEI, Oct. 31, 2022 /PRNewswire/ -- Aleees (TWSE: 5227), the Taiwan-based lithium-iron phosphate ("LFP") cathode battery material manufacturer will provide state-of-the-art LFP process technology to ICL,a leading global specialty minerals company to develop a $400 million lithium iron phosphate...
2022-10-31 16:59
3708
Full Truck Alliance Co. Ltd. Announces Gross Transaction Value for the Third Quarter of 2022
GUIYANG, China, Oct. 31, 2022 /PRNewswire/ -- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM), a leading digital freight platform, today announced that the Company facilitated 33.5 million fulfilled orders with Gross Transaction Value ("GTV") ofRMB69.6 billion in the third quart...
2022-10-31 16:00
2830
Sungrow Accomplished 3GW PV and 600MWh+ BESS Contracts during All Energy Australia 2022
MELBOURNE, Australia, Oct. 31, 2022 /PRNewswire/ -- From 26th to 27th October, Sungrow, the global leading inverter and energy storage solution supplier for renewables, achieved altogether 3GW distribution contracts of PV inverters and over 600MWh BESS contracts with several renowned RE players i...
2022-10-31 15:06
4795
Haegin "Play Together", updates Arabic to the language options
* "Play Together" localized for Middle East * Localized in 13 languages including Arabic SEOUL, South Korea, Oct. 31, 2022 /PRNewswire/ -- "Play Together", the mobile casual social network game developed and serviced by the mobile game company, Haegin (CEO Young-il Lee), has announced a new l...
2022-10-31 14:00
3163
Sohu.com to Report Third Quarter 2022 Financial Results on November 14, 2022
BEIJING, Oct. 31, 2022 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), China's leading online media, video and game business group, will report its third quarter 2022 unaudited financial results onMonday, November 14, 2022, before U.S. market hours. Sohu's management team will host a conferen...
2022-10-31 13:00
3416
Tuya Announced a Partnership with WinSharp to Accelerate the Digitalization of India's Manufacturing Industry
SANTA CLARA, Calif., Oct. 31, 2022 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global IoT development platform service provider, recently announced a partnership with WinSharp, an innovativeIndian manufacturing enterprise. Tuya will assist WinSharp inIndia by implementing its smart ma...
2022-10-31 10:05
3131
Akeso Announces Oral Presentation of Ivonescimab (PD-1/VEGF Bi-Specific) in First-line Treatment of ES-SCLC on ACLC 2022
HONG KONG, Oct. 30, 2022 /PRNewswire/ -- Akeso, Biopharma (9926. HK) ("Akeso") released the Phase Ib clinical results of Ivonescimab (PD-1/VEGF bi-specific, AK112) in combination with etoposide and carboplatin in first-line treatment of extensive-stage small-cell lung cancer(ES-SCLC), in an oral ...
2022-10-31 08:40
2525
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11
Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00
The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
132904
Royal Bank of Canada announces agreement to acquire Yarra Capital Management
2026-11-09 21:00
10484
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
2026-11-09 23:00
9713
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
2026-11-10 22:17
8197
